Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
NewAmsterdam Pharma Company (NAMS)
NASDAQ:NAMS
RESEARCH TOOLSreports
Holding NAMS?
Track your performance easily
NAMS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$15.19 - $27.29
Previous CloseN/A
Volume118.30K
Average Volume (3M)1.08M
Market Cap
$2.52B
Enterprise Value$1.15B
Total Cash (Recent Filing)$1.37M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.78
Next Earnings
Mar 28, 2025EPS Estimate
-0.49Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding106,832,954
10 Day Avg. Volume611,337
30 Day Avg. Volume1,083,120
Standard Deviation0.21
R-Squared0.00
Alpha0.06
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)66.49
Price to Cash Flow (P/CF)-43.60
P/FCF Ratio0.00
Enterprise Value/Market Cap0.46
Enterprise Value/Revenue36.66
Enterprise Value/Gross Profit81.67
Enterprise Value/Ebitda-20.98
Forecast
1Y Price Target
$43.83Price Target Upside96.64% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
NewAmsterdam Pharma Company News
PremiumCompany Announcements
NewAmsterdam Pharma Achieves Key Milestones in 2024
Ownership Overview
16.70% Insiders
0.95% Mutual Funds
0.03% Other Institutional Investors
81.52% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
NAMS FAQ
What was NewAmsterdam Pharma Company’s price range in the past 12 months?
NewAmsterdam Pharma Company lowest stock price was $15.19 and its highest was $27.29 in the past 12 months.
What is NewAmsterdam Pharma Company’s market cap?
NewAmsterdam Pharma Company’s market cap is $2.52B.
When is NewAmsterdam Pharma Company’s upcoming earnings report date?
NewAmsterdam Pharma Company’s upcoming earnings report date is Mar 28, 2025 which is in 54 days.
How were NewAmsterdam Pharma Company’s earnings last quarter?
NewAmsterdam Pharma Company released its earnings results on Nov 06, 2024. The company reported -$0.18 earnings per share for the quarter, beating the consensus estimate of -$0.499 by $0.319.
Is NewAmsterdam Pharma Company overvalued?
According to Wall Street analysts NewAmsterdam Pharma Company’s price is currently Undervalued.
Does NewAmsterdam Pharma Company pay dividends?
NewAmsterdam Pharma Company does not currently pay dividends.
What is NewAmsterdam Pharma Company’s EPS estimate?
NewAmsterdam Pharma Company’s EPS estimate is -0.49.
How many shares outstanding does NewAmsterdam Pharma Company have?
NewAmsterdam Pharma Company has 106,832,954 shares outstanding.
What happened to NewAmsterdam Pharma Company’s price movement after its last earnings report?
NewAmsterdam Pharma Company reported an EPS of -$0.18 in its last earnings report, beating expectations of -$0.499. Following the earnings report the stock price went up 13.734%.
Which hedge fund is a major shareholder of NewAmsterdam Pharma Company?
Currently, no hedge funds are holding shares in NAMS
---
NewAmsterdam Pharma Company Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$43.83 (96.64% Upside)
$43.83 (96.64% Upside)
Blogger Sentiment
Bullish
NAMS Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 937.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▲ 0.2%
Last 30 Days ▲ 3.6%
Last 30 Days ▲ 3.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Company Description
NewAmsterdam Pharma Company
Frazier Lifesciences Acquisition Corp is a blank check company.
---
NAMS Stock 12 Month Forecast
Average Price Target
$43.83
▲(96.64% Upside)
Technical Analysis
Amarin
―
Madrigal Pharmaceuticals
―
Esperion
―
Viking Therapeutics
―
Akero Therapeutics
―
Best Analysts Covering NAMS
1 Year
1 Year Success Rate
12/16 ratings generated profit
1 Year Average Return
+38.13%
reiterated a buy rating 18 days ago
Copying Roanna Ruiz's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +38.13% per trade.
---